2019 International Congress Archives - Page 14 of 217

1:45pm-3:15pm: Changes in close relationships among patients with Parkinson’s disease and their partners following initiation of device-aided treatment

J. Timpka, M. Scharfenort, T. Sahlström, V. Hernström, T. Henriksen, D. Nyholm, P. Odin (Lund, Sweden)

Quality of Life · Les Muses Terrace, Level 3

1:45pm-3:15pm: Changes in GABAergic transmission of striatal neurons in presymptomatic Huntington’s Disease

M. Treven, F. Zirpel, I. Mody (Vienna, Austria)

Huntington’s Disease · Agora 3 West, Level 3

1:45pm-3:15pm: Changes in Supine Blood Pressure with Long Term Use of Droxidopa

S. Gorny, L. Hewitt, A. Lindsten, M. Karnik-Henry, S. Kymes, A. Favit (Deerfield, IL, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Changes to Speech Production after SpeechVive Treatment in Individuals with Parkinson’s Disease

J. Huber, E. Stathopoulos, J. Sussman, K. Richardson, D. Matheron, S. Snyder (West Lafayette, IN, USA)

Clinical Trials, Pharmacology and Treatment · Agora 3 West, Level 3

1:45pm-3:15pm: Characterization of cerebrospinal fluid profile in hereditary spastic paraparesis 10

M. Andréasson, K. Lagerstedt-Robinson, K. Samuelsson, G. Solders, K. Blennow, M. Paucar, P. Svenningsson (Stockholm, Sweden)

Rare Genetic and Metabolic Diseases · Les Muses Terrace, Level 3

1:45pm-3:15pm: Characterization of impulsivity in Colombian patients with Huntington’s disease

L. Colmenares, C. Rodriguez, W. Fernandez (Bogotá, Colombia)

Huntington’s Disease · Agora 3 West, Level 3

1:45pm-3:15pm: Chlorogenic acid attenuates the MPTP induced apoptosis in Parkinson’s disease mouse model through pAkt signaling pathway

S. Singh, S. Singh (Varanasi, India)

Neuropharmacology · Les Muses Terrace, Level 3

1:45pm-3:15pm: Chorea-acanthocytosis: Challenges in early diagnosis and excellent treatment response to Deep Brain Stimulation (DBS) – a case report

J. Walch, F. Brugger, D. Brogle, R. Bauer, S. Haegele-Link, G. Kägi (St. Gallen, Switzerland)

Choreas (Non-Huntington’s Disease) · Les Muses, Level 3

1:45pm-3:15pm: Classification of Neurorehabilitation treatments: Preliminary results of a Multicentre Italian Study

T. Bowman, F. Mestanza Mattos, R. Russo, M. Boninsegna, F. Marazzini, A. Marianelli, E. Pelosin, M. Putzolu, C. Cosentino, M. Petrarca, F. Tirinelli, M. Tondinelli, F. Trecate, M. Budel, A. Turolla, M. Agostini, D. Munari, P. Pillastrini, M. Branchini, D. Lunedei, G. Sgubin, D. Cattaneo, S. Mezzarobba (Milano, Italy)

Physical and Occupational Therapy · Les Muses Terrace, Level 3

1:45pm-3:15pm: Classification of spinocerebellar degeneration based on ratio of brainstem white matter to cerebellar gray matter by voxel-based morphometry

T. Taguchi, K. Nanri, H. Kato, H. Terashi, H. Aizawa (Tokyo, Japan)

Ataxia · Les Muses, Level 3